{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:08:40Z","timestamp":1791212920422,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.leukres.2016.04.008","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T18:15:17Z","timestamp":1460484917000},"page":"30-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion"],"prefix":"10.1016","volume":"46","author":[{"given":"Mar\u00eda","family":"Hern\u00e1ndez-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana E.","family":"Rodr\u00edguez-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-\u00c1ngel","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lumbreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Eugenia","family":"Sarasquete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-\u00c1frica","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vicente-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia de las","family":"Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Nicol\u00e1s","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Alcoceba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso Garc\u00eda de","family":"Coca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas-Mar\u00eda","family":"Hern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2016.04.008_bib0005","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2016.04.008_bib0010","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2016.04.008_bib0015","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1182\/blood-2007-07-099432","article-title":"Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia","volume":"112","author":"Kujawski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/gcc.20885","article-title":"13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia","volume":"50","author":"Dal Bo","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2016.04.008_bib0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.13862","article-title":"A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia","volume":"94","author":"Hernandez","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2016.04.008_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjh.12479","article-title":"Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion","volume":"163","author":"Puiggros","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2016.04.008_bib0035","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2141.2009.07982.x","article-title":"A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia","volume":"148","author":"Van Dyke","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2016.04.008_bib0040","doi-asserted-by":"crossref","first-page":"e48485","DOI":"10.1371\/journal.pone.0048485","article-title":"Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14","volume":"7","author":"Rodriguez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2016.04.008_bib0045","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1101\/gad.1184404","article-title":"Specificity of microRNA target selection in translational repression","volume":"18","author":"Doench","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.leukres.2016.04.008_bib0050","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.04.008_bib0055","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2016.04.008_bib0060","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1073\/pnas.0404432101","article-title":"MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.04.008_bib0065","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2006-12-062398","article-title":"Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia","volume":"109","author":"Fulci","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0070","doi-asserted-by":"crossref","first-page":"e16956","DOI":"10.1371\/journal.pone.0016956","article-title":"MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2016.04.008_bib0075","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2008-09-178186","article-title":"Patterns of microRNA expression characterize stages of human B-cell differentiation","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0080","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1182\/blood-2008-11-189407","article-title":"microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification","volume":"113","author":"Stamatopoulos","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0085","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","article-title":"Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia","volume":"122","author":"Ferrajoli","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0090","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2010-01-263889","article-title":"microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival","volume":"116","author":"Rossi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0095","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/1078-0432.CCR-13-2497","article-title":"microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters","volume":"20","author":"Negrini","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2016.04.008_bib0100","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2009-06-229211","article-title":"Karyotype-specific microRNA signature in chronic lymphocytic leukemia","volume":"114","author":"Visone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0105","first-page":"1419","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1977","volume":"10","author":"Harris","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2016.04.008_bib0110","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1182\/blood-2005-04-1677","article-title":"Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia","volume":"107","author":"Binet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0115","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1182\/blood-2003-01-0045","article-title":"Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone","volume":"102","author":"Sanchez","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.leukres.2016.04.008_bib0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0076-6879(06)11009-5","article-title":"TM4 microarray software suite","volume":"411","author":"Saeed","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.leukres.2016.04.008_bib0130","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.04.008_bib0135","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1349-7006.2007.00618.x","article-title":"Downregulation of microRNAs-143 and \u2212145 in B-cell malignancies","volume":"98","author":"Akao","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2016.04.008_bib0140","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1158\/0008-5472.CAN-11-3671","article-title":"miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells","volume":"72","author":"Kovaleva","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2016.04.008_bib0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2119\/molmed.2013.00005","article-title":"Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia","volume":"19","author":"Papakonstantinou","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.leukres.2016.04.008_bib0150","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/onc.2008.474","article-title":"Role of miR-143 targeting KRAS in colorectal tumorigenesis","volume":"28","author":"Chen","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2016.04.008_bib0155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.leukres.2010.03.011","article-title":"The role of Bcl-2 family proteins in chronic lymphocytic leukaemia","volume":"34","author":"Buggins","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2016.04.008_bib0160","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V84.9.3158.3158","article-title":"The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin","volume":"84","author":"Watanabe","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0165","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M708218200","article-title":"B-cell receptor activation induces BIC\/miR-155 expression through a conserved AP-1 element","volume":"283","author":"Yin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2016.04.008_bib0170","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/onc.2013.26","article-title":"MiR-155 at the heart of oncogenic pathways","volume":"33","author":"Czyzyk-Krzeska","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2016.04.008_bib0175","doi-asserted-by":"crossref","first-page":"16170","DOI":"10.1073\/pnas.0703942104","article-title":"Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development","volume":"104","author":"Gironella","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.04.008_bib0180","doi-asserted-by":"crossref","first-page":"17869","DOI":"10.1074\/jbc.M110.101055","article-title":"MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer","volume":"285","author":"Kong","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2016.04.008_bib0185","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-09-4250","article-title":"MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene","volume":"70","author":"Jiang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2016.04.008_bib0190","doi-asserted-by":"crossref","first-page":"e64678","DOI":"10.1371\/journal.pone.0064678","article-title":"Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2016.04.008_bib0195","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2014-03-559690","article-title":"MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia","volume":"124","author":"Cui","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.008_bib0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2012.03.013","article-title":"Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma","volume":"181","author":"Huang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.leukres.2016.04.008_bib0205","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/emboj.2012.45","article-title":"A novel miR-155\/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells","volume":"31","author":"Jiang","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.leukres.2016.04.008_bib0210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/cmi.2009.45","article-title":"MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C\/EBPbeta","volume":"6","author":"He","year":"2009","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.leukres.2016.04.008_bib0215","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.04.008_bib0220","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1586\/ehm.12.54","article-title":"MicroRNAs in chronic lymphocytic leukemia: from causality to associations and back","volume":"5","author":"Mraz","year":"2012","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.leukres.2016.04.008_bib0225","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.04.008_bib0230","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1158\/0008-5472.CAN-07-3105","article-title":"Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14","volume":"68","author":"Ouillette","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2016.04.008_bib0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/path.2333","article-title":"miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC\/miR-155 expression","volume":"215","author":"Wang","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.leukres.2016.04.008_bib0240","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5507\/bp.2013.057","article-title":"Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia","volume":"157","author":"Humplikova","year":"2013","journal-title":"Biomed. Pap. Med. Fac. Univ. Palack\u00fd Olomouc Czechoslov"},{"key":"10.1016\/j.leukres.2016.04.008_bib0245","first-page":"5641","article-title":"Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion","volume":"16","author":"Mosca","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2016.04.008_bib0250","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0609.2008.01086.x","article-title":"Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: cytogenetic, FISH and clinical studies","volume":"81","author":"Chena","year":"2008","journal-title":"Eur. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T14:00:37Z","timestamp":1600437637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616300480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":50,"alternative-id":["S0145212616300480"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.04.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}